FindTrial
Sign In

Research and development cultivation team for blood-based biomarker reagents in Intervertebral disc degenerative disease

Research and validation of blood test markers for intervertebral disc degeneration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002199
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-06-04
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative disc disease

Interventions

Healthy Human Sample Bank:Interference Substance Research

Sponsors

Beijing Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 65 gender without limit. Healthy individuals who have normal blood sugar levels liver and kidney function (BUN CRE ALT AST) and lipid profiles (TC TG). Physical examinations CT scans and chest X-rays show no significant abnormalities.

Exclusion criteria

Exclusion criteria: The supplementary rheumatoid factor test results were abnormal. The residual serum samples after testing showed hemolysis lipemia or icterus.

Design outcomes

Primary

MeasureTime frame
METRN;—

Countries

China

Contacts

Public ContactJie Guo

Wangjing Hospital of China Academy of Chinese Medical Sciences

guojielab@163.com13466768893

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026